Surgery Partners (NASDAQ: SGRY) has recently received a number of price target changes and ratings updates:
- 10/28/2026 – Surgery Partners was downgraded by UBS Group from “buy” to “hold”. They now have a $23.50 price target on the stock, up from $21.00.
- 10/27/2026 – Surgery Partners was downgraded by Stonex Financia from “strong-buy” to “hold”.
- 10/26/2026 – Surgery Partners was given a new $23.50 price target by Raymond James Financial.
- 10/26/2026 – Surgery Partners was downgraded by Cantor Fitzgerald from “overweight” to “hold”.
- 10/26/2026 – Surgery Partners was downgraded by Royal Bank Of Canada from “moderate buy” to “hold”. They now have a $23.50 price target on the stock.
- 10/16/2026 – Surgery Partners was upgraded by Weiss Ratings from “sell (e+)” to “sell (d-)”.
- 10/2/2026 – Surgery Partners had its “overweight” rating reaffirmed by Cantor Fitzgerald.
- 9/30/2026 – Surgery Partners had its “outperform” rating reaffirmed by Royal Bank Of Canada. They now have a $19.00 price target on the stock.
- 9/18/2026 – Surgery Partners had its “buy” rating reaffirmed by TD Cowen. They now have a $19.00 price target on the stock.
- 9/14/2026 – Surgery Partners had its price target raised by JPMorgan Chase & Co. from $14.00 to $15.00. They now have a “neutral” rating on the stock.
Insider Buying and Selling
In other news, Director Teresa DeLuca bought 10,000 shares of the business’s stock in a transaction on Tuesday, August 18th. The stock was purchased at an average cost of $14.35 per share, for a total transaction of $143,500.00. Following the completion of the transaction, the director directly owned 66,843 shares of the company’s stock, valued at approximately $959,197.05. This trade represents a 17.59% increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. 2.00% of the stock is currently owned by insiders.
Its facilities provide surgical services across specialties such as orthopedics, pain management, ophthalmology, gastroenterology, urology, gynecology and general surgery. Surgery Partners also supports its operations with clinical, administrative and revenue-cycle services intended to help physicians and facility partners manage patient care and practice operations.
Founded in 2004 and headquartered in Brentwood, Tennessee, Surgery Partners has expanded its platform through acquisitions, joint ventures and other partnerships.
Read More
- Five stocks we like better than Surgery Partners
- Phillips 66 Posts Strong Earnings But the Stock Doesn’t Care
- NXP Semiconductors Falls After Strong Earnings—Is the Sell-Off Overdone?
- GE Vernova’s Reservations Are Turning Into Real Orders—But the Market Still Wants More.
- Where’s the Beef? Trian-Led Buyout Proposal Values Wendy’s at $1.4B, But Is It Enough?
Receive News & Ratings for Surgery Partners Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Surgery Partners Inc and related companies with MarketBeat.com's FREE daily email newsletter.
